Big Pharma Round-Up III

A lot happened in the world of pharmaceuticals this year. The opioid crisis worsened. The FDA got a new chief. There were big failures and prices reemerged as a major issue. Industry needed to contend with the new Trump administration and gene therapy ‘came of age.’ By the way, here is one year in reviewContinue reading “Big Pharma Round-Up III”